JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.14 Billion CNY | -23.12% |
| 2022 | 2.79 Billion CNY | -10.44% |
| 2021 | 3.11 Billion CNY | -17.54% |
| 2020 | 3.77 Billion CNY | 465.27% |
| 2019 | 668.61 Million CNY | 96.18% |
| 2018 | 340.82 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.97 Billion CNY | -7.75% |
| 2024 Q2 | 1.97 Billion CNY | 0.0% |
| 2023 FY | 2.14 Billion CNY | -23.12% |
| 2023 Q3 | 2.14 Billion CNY | -19.09% |
| 2023 Q2 | 2.65 Billion CNY | 0.0% |
| 2023 Q1 | 2.65 Billion CNY | -4.98% |
| 2023 Q4 | 2.14 Billion CNY | 0.0% |
| 2022 Q4 | 2.79 Billion CNY | 0.0% |
| 2022 Q2 | 2.89 Billion CNY | 0.0% |
| 2022 Q1 | 2.89 Billion CNY | -7.11% |
| 2022 FY | 2.79 Billion CNY | -10.44% |
| 2022 Q3 | 2.79 Billion CNY | -3.58% |
| 2021 Q1 | 3.48 Billion CNY | -7.8% |
| 2021 FY | 3.11 Billion CNY | -17.54% |
| 2021 Q4 | 3.11 Billion CNY | 0.0% |
| 2021 Q3 | 3.11 Billion CNY | -10.56% |
| 2021 Q2 | 3.48 Billion CNY | 0.0% |
| 2020 FY | 3.77 Billion CNY | 465.27% |
| 2020 Q1 | 2.02 Billion CNY | 202.81% |
| 2020 Q3 | 3.77 Billion CNY | 86.68% |
| 2020 Q2 | 2.02 Billion CNY | 0.0% |
| 2020 Q4 | 3.77 Billion CNY | 0.0% |
| 2019 Q3 | 668.61 Million CNY | 0.0% |
| 2019 FY | 668.61 Million CNY | 96.18% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 668.61 Million CNY | 0.0% |
| 2018 FY | 340.82 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -5424.486% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -29625.315% |
| SQZ Biotechnologies Company | 107.18 Million USD | -1902.199% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -20234.442% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -1548.172% |
| Mesoblast Limited | 667.9 Million USD | -221.32% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -2965556.049% |
| Genus plc | 1.02 Billion USD | -108.582% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -157892.584% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -429945.948% |
| Marizyme, Inc. | 22.01 Million USD | -9648.307% |
| ContraFect Corporation | 20.67 Million USD | -10278.147% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -342180.223% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -549665.348% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -561445.305% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -149763.76% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -51662.798% |
| MultiCell Technologies, Inc. | 126.22 USD | -1700282739.487% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -228283.752% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -1569.984% |
| EV Biologics, Inc. | 431.71 Thousand USD | -497010.819% |
| Q BioMed Inc. | 3.51 Million USD | -60946.412% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -6000.506% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -278380.985% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -821287.646% |
| Biomind Labs Inc. | 73.81 Thousand USD | -2907142.038% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -363.666% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -7050.093% |
| Skye Bioscience, Inc. | 11.94 Million USD | -17873.393% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -64677.822% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -78044.036% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -109496.009% |
| IMV Inc. | 31.33 Million USD | -6749.147% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -312065.92% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -82340.853% |
| GB Sciences, Inc. | 103.44 Thousand USD | -2074586.298% |
| Alpha Cognition Inc. | 2.45 Million USD | -87418.28% |
| HST Global, Inc. | 1526.00 USD | -140635352.163% |
| CSL Limited | 38.02 Billion USD | 94.356% |
| Halberd Corporation | 10.13 Thousand USD | -21183366.588% |
| Enzolytics Inc. | 361.7 Million USD | -493.325% |
| Resverlogix Corp. | 8.11 Million USD | -26346.051% |
| Affymax, Inc. | 7.44 Million USD | -28733.763% |
| SYBLEU INC | 330.46 Thousand USD | -649311.441% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -114182.968% |
| argenx SE | 4.54 Billion USD | 52.755% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -7579.992% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -4398.967% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -9420456.604% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -23881.002% |
| AVAX Technologies, Inc. | 7.37 Million USD | -28991.112% |
| Zenith Capital Corp. | 7410.00 USD | -28962072.74% |
| Genscript Biotech Corporation | 3.38 Billion USD | 36.626% |
| Ember Therapeutics, Inc. | 184.00 USD | -1166356965.217% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -666791.543% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -821014.231% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -380.855% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -148024.883% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -70843.338% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -3972.213% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -231170.172% |
| BioStem Technologies, Inc. | 14.56 Million USD | -14639.383% |
| ONE Bio Corp. | 70.08 Million USD | -2962.112% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -3758783.595% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -92904532.035% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -217123.551% |
| Agentix Corp. | 261.39 Thousand USD | -820926.275% |
| LadRx Corporation | 2.3 Million USD | -92889.893% |
| Cell Source, Inc. | 195.17 Thousand USD | -1099498.301% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -446485.317% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -606798.707% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -606798.707% |
| NovAccess Global Inc. | 62.24 Thousand USD | -3447556.15% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -335407.992% |
| Itoco Inc. | 1.4 Million USD | -153184.76% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -2243433.667% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -2024519.811% |
| Kadimastem Ltd | 2.3 Million USD | -93043.337% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -2810619.805% |
| CytoDyn Inc. | 11.13 Million USD | -19171.704% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -1500961.047% |
| Mobile Lads Corp. | 52.00 USD | -4127109515.385% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -12002679.642% |
| Qrons Inc. | 420.00 USD | -510975376.19% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -556646.681% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -388601.188% |
| Rebus Holdings, Inc. | 5000.00 USD | -42921840.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -524077.255% |
| International Stem Cell Corporation | 5.39 Million USD | -39716.271% |
| Bioxytran, Inc. | 137.63 Thousand USD | -1559132.915% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -14205.568% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -12844.671% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -2716478.481% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -248096.379% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -28449.914% |
| Neutra Corp. | 2851.00 USD | -75275136.759% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -6522.53% |
| PureTech Health plc | 693.97 Million USD | -209.248% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -26489.931% |
| IXICO plc | 15.84 Million USD | -13445.255% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -25812.787% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -1977.056% |
| CSL Limited | 38.02 Billion USD | 94.356% |
| Cellectis S.A. | 333.99 Million USD | -542.554% |